MEDANTA.NS Cash Flow
Global Health Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹6.45 Bn | ₹6.12 Bn | ₹6.24 Bn | ₹7.14 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-3.42 Bn | ₹-4.41 Bn | ₹-7.21 Bn | ₹-10.65 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹3.46 Bn | ₹-5.14 Bn | ₹-0.97 Bn | ₹2.48 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | ₹0.00 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹6.48 Bn | ₹-3.43 Bn | ₹-1.94 Bn | ₹-1.03 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹1.19 Bn | ₹7.67 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from MEDANTA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).